<DOC>
	<DOCNO>NCT01944176</DOCNO>
	<brief_summary>Airway inflammation partly drive Th17 Th17-polarizing cytokine steroid-resistant . Statins could suppress IL-17 cytokine diseases atherosclerosis multiple sclerosis mouse model . The investigator hypothesize statin might provide anti-inflammatory benefit suppress IL-17 cytokine COPD patient .</brief_summary>
	<brief_title>The Effects Simvastatin Th17 Cytokines Th17 Polarizing Cytokine COPD Patients</brief_title>
	<detailed_description />
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Stable COPD without exacerbation within 3 month prior study entry mild , moderate severe COPD without treatment , regardless COPD medication Concomitant chronic lung diseases include TB malignancy HIV Being immunosuppressive drug systemic corticosteroid Dyslipidemic patient recent cardiovascular cerebrovascular disease within 6 month prior study entry Cognitive impairment Currently macrolides , azole antifungal agent , amiodarone amlodipine</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>Statins</keyword>
	<keyword>Cytokines</keyword>
</DOC>